Knight Therapeutics, Inc. (GUD.TO)
9.75
+0.09
(+0.93%)
CAD |
TSX |
Aug 25, 16:00
Knight Therapeutics Total Assets (Quarterly) : 1.045B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.045B |
| March 31, 2026 | 1.087B |
| December 31, 2025 | 1.046B |
| September 30, 2025 | 1.049B |
| June 30, 2025 | 1.038B |
| March 31, 2025 | 1.003B |
| December 31, 2024 | 963.80M |
| September 30, 2024 | 962.29M |
| June 30, 2024 | 945.36M |
| March 31, 2024 | 968.20M |
| December 31, 2023 | 945.49M |
| September 30, 2023 | 1.011B |
| June 30, 2023 | 1.014B |
| March 31, 2023 | 1.045B |
| December 31, 2022 | 1.055B |
| September 30, 2022 | 1.035B |
| June 30, 2022 | 1.001B |
| March 31, 2022 | 995.42M |
| December 31, 2021 | 991.89M |
| September 30, 2021 | 1.038B |
| June 30, 2021 | 1.044B |
| March 31, 2021 | 1.001B |
| December 31, 2020 | 1.040B |
| September 30, 2020 | 1.014B |
| June 30, 2020 | 1.225B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.267B |
| December 31, 2019 | 1.305B |
| September 30, 2019 | 1.022B |
| June 30, 2019 | 1.074B |
| March 31, 2019 | 1.058B |
| December 31, 2018 | 1.052B |
| September 30, 2018 | 1.041B |
| June 30, 2018 | 1.029B |
| March 31, 2018 | 1.017B |
| December 31, 2017 | 1.006B |
| September 30, 2017 | 993.47M |
| June 30, 2017 | 991.98M |
| March 31, 2017 | 994.29M |
| December 31, 2016 | 990.77M |
| September 30, 2016 | 877.90M |
| June 30, 2016 | 868.00M |
| March 31, 2016 | 638.34M |
| December 31, 2015 | 648.99M |
| September 30, 2015 | 627.82M |
| June 30, 2015 | 530.14M |
| March 31, 2015 | 525.42M |
| December 31, 2014 | 486.61M |
| September 30, 2014 | 261.61M |
| June 30, 2014 | 260.32M |
| March 31, 2014 | 86.48M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | 182.38M |
| Bausch Health Cos., Inc. | 35.18B |
| Cipher Pharmaceuticals, Inc. | 222.59M |
| BioSyent, Inc. | 60.46M |
| Revive Therapeutics Ltd. | 0.2818M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 246.25M |
| Shareholders Equity (Quarterly) | 798.59M |
| Debt to Equity Ratio | 0.0429 |
| Current Ratio | 2.280 |
| Net Debt Paydown Yield | 0.41% |